SIFI PRESENTED NEW DATA ON XANTERDES AT ARVO 2023
Presentations included results from preclinical and clinical studies on XanterDES, a novel lubricating ophthalmic solution, intended to alleviate ocular discomfort in dry eye patients.
- Presentations included results from preclinical and clinical studies on XanterDES, a novel lubricating ophthalmic solution, intended to alleviate ocular discomfort in dry eye patients.
- SIFI is fully committed to finding innovative solutions towards treating and managing this disease."
- "XanterDES represents an important innovation in treating dry eye due to its unique formulation and we are pleased to have presented preclinical and clinical posters on this novel eye drop."
- SIFI is a leading international ophthalmic company, headquartered in Italy, focusing on eye care since 1935.